Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Low Brand Recognition Leaves Zicam Plenty Of Room To Grow

This article was originally published in The Tan Sheet

Executive Summary

Zicam's relatively low brand name recognition represents significant growth potential for the line, Matrixx Initiatives asserted during a fourth-quarter and full-year 2005 earnings call Feb. 14

You may also be interested in...



Matrixx Eyes Antacids, Oral Care; Zicam Brand Drives 50% Sales Jump

Matrixx is concentrating research spending on antacids, analgesics and oral care as possible areas for new product development

Matrixx Plans Extensive Zicam Marketing For Upcoming Cold Season

Matrixx Initiatives will promote its Zicam and Nasal Comfort cough, cold and allergy products with an original multimedia marketing campaign in the second half of 2005

Blame China? Experts Advise Congress, Industry Take A Wider View

The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say

Topics

UsernamePublicRestriction

Register

PS099113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel